menu
    • menu

    Company profile for BioCina

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioCina is derived from “Bio” being the prefix of Biotech, and “Cina” being the suffix to Medicina, Italian for medicine or drug. BioCina has a strong history as a multi-product biologics contract development and manufacturing organization (CDMO), focused on development and cGMP manufacture of microbial-based therapeutics, from preclinical to commercial production. The site, approved by the FDA for commercial manufactu...
    BioCina is derived from “Bio” being the prefix of Biotech, and “Cina” being the suffix to Medicina, Italian for medicine or drug. BioCina has a strong history as a multi-product biologics contract development and manufacturing organization (CDMO), focused on development and cGMP manufacture of microbial-based therapeutics, from preclinical to commercial production. The site, approved by the FDA for commercial manufacturing in 2020, has 35+ years of microbial fermentation experience and over the past 15 years, has worked on over 50 different products and has partnered with more than 30 customers globally.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioCinaAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    8 Dalgleish St Thebarton South Australia 5031
    Telephone
    Telephone
    +61 8 8150 8200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biocina.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biocina/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biocinacdmo

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biocina Names Dr. Thomas Broudy As CEO
    Biocina Names Dr. Thomas Broudy As CEO

    28 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biocina-announces-appointment-of-dr-thomas-broudy-as-chief-executive-officer-302596248.html

    PR NEWSWIRE
    28 Oct 2025
    Share Share
    Australia Gains Edge as Strategic Clinical Manufacturing Gateway
    Australia Gains Edge as Strategic Clinical Manufacturing Gateway

    17 Jun 2025

    // PRESS RELEASE

    https://biocina.com/press-releases/australia-as-a-strategic-gateway/

    PRESS RELEASE
    17 Jun 2025
    Share Share
    BioCina and NovaCina Merger Bolsters Global CDMO Industry
    BioCina and NovaCina Merger Bolsters Global CDMO Industry

    13 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biocina-and-novacina-merger-bolsters-global-cdmo-industry-302348573.html

    PR NEWSWIRE
    13 Jan 2025
    Share Share
    Centivax Selects BioCina For cGMP Manufacturing Of Influenza Vaccine
    Centivax Selects BioCina For cGMP Manufacturing Of Influenza Vaccine

    10 Oct 2024

    // PRESS RELEASE

    https://biocina.com/press-releases/centivax-selects-global-cdmo-biocina-to-initiate-cgmp-manufacturing-of-revolutionary-universal-influenza-vaccine/

    PRESS RELEASE
    10 Oct 2024
    Share Share
    EnGeneIC Selects BioCina To Advance Ground-Breaking Cancer Treatment
    EnGeneIC Selects BioCina To Advance Ground-Breaking Cancer Treatment

    24 Sep 2024

    // PRESS RELEASE

    https://biocina.com/press-releases/engeneic-selects-global-cdmo-biocina-to-advance-their-ground-breaking-cancer-treatment/

    PRESS RELEASE
    24 Sep 2024
    Share Share
    CDMO BioCina Partners with CelluTx
    CDMO BioCina Partners with CelluTx

    03 Jun 2024

    // PRESS RELEASE

    https://biocina.com/press-releases/biocina-acquires-the-exclusive-cdmo-rights-for-leading-edge-minicircle-dna-technology-platform-from-cellutx/

    PRESS RELEASE
    03 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search